Twitter Facebook LinkedIn YouTube

Latest Video

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

Video Platform Video Management Video Solutions Video Player

Under the agreement, Havn Life Sciences will source naturally-derived psychedelic compounds, such as psilocybin, for use in future investigational new drug enabling studies and clinical trials under FDA guidelines.